Policy

Daniel Kelly, European Cancer Summit 2021: Eliminating HPV Cancers

Published Online: November 15th 2021

We were delighted to catch up with Prof Daniel Kelly (Cardiff University, Wales, UK) to discuss the latest policy developments in the mission of HPV cancer elimination and the gender neutral vaccination plan.

Questions
1. How are the World Health Organisation and Europe’s Beating Cancer Plan working together to tackle HPV-associated cancers? (00:20-01:18)
2. What has been the impact of the HPV vaccine in terms of cancer prevention? (01:18-02:28)
3. What are the hopes for gender neutral vaccination? (02:28-03:38)
4. Could you tell us a little about the European Cancer Organisation’s HPV Action Network and its aims? (03:38-04:43)
5. How is the HPV Action Network working to improve gender neutral vaccination availability across Europe? (04:43-05:47)

Speaker Disclosure: Daniel Kelly has no financial or non-financial conflicts of interest to declare in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Sophie Nickelson.

Filmed in coverage of the European Cancer Summit 2021

Share this Video
Related Videos In Policy
Policy
Developed by Touch
Winette van der Graaf discusses her hopes and goals as President of the EORTC
Watch Time: 6 mins

It was a pleasure to speak with Prof Winette van der Graaf (The Netherlands Cancer Institute, Amsterdam, Netherlands) to hear about her aims for the European Organisation for Research and Treatment of Cancer (EORTC) during her presidency, and the current initiatives the society are focusing on. Disclosures: Winette van der Graaf has no financial or […]

Policy
Developed by Touch
Winette van der Graaf: Looking forward to the 60th anniversary of the EORTC!
Watch Time: 4 mins

Prof Winette van der Graaf (The Netherlands Cancer Institute, Amsterdam, Netherlands) shares some exciting highlights to look forward to at the 60th anniversary event being held in September 2022 and why healthcare professionals should attend. Questions What are the key highlights of the upcoming EORTC 60th anniversary event in September? (00:25-03:23) Why should healthcare professionals […]

Policy
Developed by Touch
Winette van der Graaf celebrates the strengths of the European Organisation for Research and Treatment of Cancer
Watch Time: 3 mins

Prof Winette van der Graaf (The Netherlands Cancer Institute, Amsterdam, Netherlands) celebrates strengths of the European Organisation for Research and Treatment of Cancer (EORTC) and what makes the society unique. She also adds that an ongoing major challenge is obtaining funding for clinical trials and how they are trying to overcome this. Disclosures: Winette van […]

Trending In Policy:

Winette van der Graaf discusses her hopes and goals as President of the EORTC
Policy
    • Copied to clipboard!
    accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72